Compare Thermo Fisher Scientific, Inc. with Similar Stocks
Dashboard
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 11.00
2
Healthy long term growth as Net Sales has grown by an annual rate of 10.48% and Operating profit at 11.37%
3
Flat results in Jun 25
4
With ROCE of 10.03%, it has a attractive valuation with a 2.55 Enterprise value to Capital Employed
Stock DNA
Pharmaceuticals & Biotechnology
USD 197,006 Million (Large Cap)
28.00
NA
0.34%
0.55
13.09%
3.69
Revenue and Profits:
Net Sales:
11,005 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,656 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.12%
0%
-3.12%
6 Months
-12.25%
0%
-12.25%
1 Year
20.94%
0%
20.94%
2 Years
-14.98%
0%
-14.98%
3 Years
-4.65%
0%
-4.65%
4 Years
-8.48%
0%
-8.48%
5 Years
10.23%
0%
10.23%
Thermo Fisher Scientific, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.70%
EBIT Growth (5y)
1.17%
EBIT to Interest (avg)
11.00
Debt to EBITDA (avg)
2.32
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
0.51
Tax Ratio
6.68%
Dividend Payout Ratio
9.70%
Pledged Shares
0
Institutional Holding
96.52%
ROCE (avg)
13.03%
ROE (avg)
16.96%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
3.69
EV to EBIT
26.98
EV to EBITDA
20.28
EV to Capital Employed
2.73
EV to Sales
5.08
PEG Ratio
2.54
Dividend Yield
0.34%
ROCE (Latest)
10.12%
ROE (Latest)
13.09%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 264 Schemes (33.84%)
Foreign Institutions
Held by 786 Foreign Institutions (29.77%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
11,005.00
12,215.00
-9.91%
Operating Profit (PBDIT) excl Other Income
2,707.00
3,181.00
-14.90%
Interest
450.00
474.00
-5.06%
Exceptional Items
-3.00
-89.00
96.63%
Consolidate Net Profit
1,656.00
1,970.00
-15.94%
Operating Profit Margin (Excl OI)
179.10%
200.90%
-2.18%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -9.91% vs 9.83% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -15.94% vs 21.53% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
44,556.00
42,879.00
3.91%
Operating Profit (PBDIT) excl Other Income
11,178.00
10,770.00
3.79%
Interest
1,703.00
1,654.00
2.96%
Exceptional Items
-298.00
-73.00
-308.22%
Consolidate Net Profit
6,720.00
6,338.00
6.03%
Operating Profit Margin (Excl OI)
188.50%
178.70%
0.98%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.91% vs 0.05% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 6.03% vs 6.43% in Dec 2024
About Thermo Fisher Scientific, Inc. 
Thermo Fisher Scientific, Inc.
Pharmaceuticals & Biotechnology
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for a range of applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.
Company Coordinates 
Company Details
168 3rd Ave , WALTHAM MA : 02451-7551
Registrar Details






